H2G Green Limited’s Strategic Rights Issue: A Potential Game Changer for Shareholders

H2G Green Limited has announced a significant financial maneuver that could have substantial implications for its shareholders and potentially impact its share price. The company is proposing a renounceable non-underwritten rights issue of up to 1,415,284,092 warrants at an issue price of S\$0.001 per warrant. Each warrant will enable shareholders to subscribe for one new ordinary share in the company at an exercise price of S\$0.004.

Key Details of the Rights Issue

The rights issue is structured on a one-for-one basis, meaning shareholders will receive one warrant for each existing share held. This opportunity is available to Entitled Shareholders, consisting of Entitled Depositors and Entitled Scripholders, as of the record date set for 18 November 2024 at 5.00 p.m. (Singapore time). The shares will trade on a “cum-rights” basis until 14 November 2024 and on an “ex-rights” basis from 15 November 2024.

Eligibility and Participation

Entitled Shareholders will receive instructions on accessing the Offer Information Statement (OIS) and can choose to accept, decline, or renounce their provisional allotments. Shareholders under the Supplementary Retirement Scheme and Central Provident Fund Investment Scheme can participate using funds from their respective accounts, subject to applicable rules.

Foreign Shareholders

Importantly, the rights issue does not extend to shareholders with registered addresses outside Singapore, unless they provide a Singapore address to the Share Registrar or CDP at least three market days before the record date. The OIS and related documents will not be distributed outside Singapore, and no provisional allotments will be made to Foreign Shareholders.

Potential Implications for Shareholders

This announcement is pivotal for shareholders as it presents an opportunity to increase their stake in the company at a relatively low cost. However, there is inherent uncertainty since the rights issue is subject to certain conditions and may not be completed as anticipated. Shareholders are advised to exercise caution and stay informed about further announcements regarding the rights issue.

By Order of the Board,

Lim Shao-Lin
Executive Director, CEO
8 November 2024

Disclaimer

This article does not constitute financial advice. Shareholders should consult with financial advisors to understand the implications of the rights issue. The information is based on the company’s latest announcement and may be subject to change.